Presentation Comparative Outcomes for Patients Who Do and Do Not Undergo PCI for Stable CAD in New York Presenter: Edward L. Hannan April 02, 2012
Presentation Short- vs. Long-term Duration of Dual Antiplatelet Therapy (DAPT) After Coronary Stenting Presenter: Marco Valgimigli April 02, 2012
Presentation RAPID GENE: Point-of-Care Genetic Testing for Personalization of Antiplatelet Treatment Presenter: J.D. Roberts March 29, 2012
Presentation Longitudinal stent deformation: Quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomized controlled clinical trials Presenter: 53202|Dean Kereiakes March 28, 2012
Presentation ACC 2012 Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions Presenter: Gregg Stone March 28, 2012
Presentation ACC 2012 Final Results from the ACCF-STS Database Collaboration on the Comparative Effectiveness of Revascularization Strategies (ASCERT) Presenter: 196412|William Weintraub March 27, 2012
Presentation ACC 2012 Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of The PARTNER Trial Presenter: Susheel K. Kodali March 26, 2012
Presentation ACC 2012 Drug-Eluting Balloons: Novel Technology and Applications Presenter: Sigmund Silber March 26, 2012
Presentation ACC 2012 A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial Presenter: Myeong-Ki Hong March 25, 2012
Presentation ACC 2012 Renal Sympathetic Denervation for Treatment of Resistant Hypertension: One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Presenter: Murray Esler March 25, 2012